Limits...
Hormone receptor status in breast cancer and its relation to age and other prognostic factors.

Pourzand A, Fakhree MB, Hashemzadeh S, Halimi M, Daryani A - Breast Cancer (Auckl) (2011)

Bottom Line: Also, compared with older women, young women had tumors that were more likely to be large in size and have higher stages (P < 0.05).Furthermore patients with negative progesterone receptor status were more likely to have HER-2 overexpression (P < 0.05).The differences in propensity to lymph node metastasis between hormone receptor statuses were not statically significant.

View Article: PubMed Central - PubMed

Affiliation: Department of General Surgery, Imam Reza Hospital, Tabriz University of Medical Sciences, Iran.

ABSTRACT

Background: Increasing evidence shows the importance of young age, estrogen receptor (ER), progesterone receptor (PR) status, and HER-2 expression in patients with breast cancers.

Patients and methods: We organized an analytic cross-sectional study of 105 women diagnosed with breast cancer who have been operated on between 2008 to 2010. We evaluated age, size, hormone receptor status, HER-2 and P53 expression as possible indicator of lymph node involvement.

Results: There is a direct correlation between positive progesterone receptor status and being younger than 40 (P < 0.05). Also, compared with older women, young women had tumors that were more likely to be large in size and have higher stages (P < 0.05). Furthermore patients with negative progesterone receptor status were more likely to have HER-2 overexpression (P < 0.05). The differences in propensity to lymph node metastasis between hormone receptor statuses were not statically significant.

Conclusions: Although negative progesterone receptor tumors were more likely to have HER-2 overexpression, it is possible that higher stage and larger size breast cancer in younger women is related to positive progesterone receptor status.

No MeSH data available.


Related in: MedlinePlus

Younger women had tumors that were more likely to have higher stage (A), larger size (B), and progesterone receptor positive (C).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3117624&req=5

f1-bcbcr-1-2011-087: Younger women had tumors that were more likely to have higher stage (A), larger size (B), and progesterone receptor positive (C).

Mentions: Tumor characteristics in younger women also were significantly different from tumor characteristics in older women. Younger women had tumors that were more likely to have higher stage, larger size, and progesterone receptor positive (P < 0.05) as shown in Figure 1. Tumor characteristics of the two age groups are summarized in Table 1.


Hormone receptor status in breast cancer and its relation to age and other prognostic factors.

Pourzand A, Fakhree MB, Hashemzadeh S, Halimi M, Daryani A - Breast Cancer (Auckl) (2011)

Younger women had tumors that were more likely to have higher stage (A), larger size (B), and progesterone receptor positive (C).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3117624&req=5

f1-bcbcr-1-2011-087: Younger women had tumors that were more likely to have higher stage (A), larger size (B), and progesterone receptor positive (C).
Mentions: Tumor characteristics in younger women also were significantly different from tumor characteristics in older women. Younger women had tumors that were more likely to have higher stage, larger size, and progesterone receptor positive (P < 0.05) as shown in Figure 1. Tumor characteristics of the two age groups are summarized in Table 1.

Bottom Line: Also, compared with older women, young women had tumors that were more likely to be large in size and have higher stages (P < 0.05).Furthermore patients with negative progesterone receptor status were more likely to have HER-2 overexpression (P < 0.05).The differences in propensity to lymph node metastasis between hormone receptor statuses were not statically significant.

View Article: PubMed Central - PubMed

Affiliation: Department of General Surgery, Imam Reza Hospital, Tabriz University of Medical Sciences, Iran.

ABSTRACT

Background: Increasing evidence shows the importance of young age, estrogen receptor (ER), progesterone receptor (PR) status, and HER-2 expression in patients with breast cancers.

Patients and methods: We organized an analytic cross-sectional study of 105 women diagnosed with breast cancer who have been operated on between 2008 to 2010. We evaluated age, size, hormone receptor status, HER-2 and P53 expression as possible indicator of lymph node involvement.

Results: There is a direct correlation between positive progesterone receptor status and being younger than 40 (P < 0.05). Also, compared with older women, young women had tumors that were more likely to be large in size and have higher stages (P < 0.05). Furthermore patients with negative progesterone receptor status were more likely to have HER-2 overexpression (P < 0.05). The differences in propensity to lymph node metastasis between hormone receptor statuses were not statically significant.

Conclusions: Although negative progesterone receptor tumors were more likely to have HER-2 overexpression, it is possible that higher stage and larger size breast cancer in younger women is related to positive progesterone receptor status.

No MeSH data available.


Related in: MedlinePlus